Global and United States Biosimilars/follow-on-biologics Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 06-Oct-2020
No. of pages: 91
Inquire Before Buying

Global Biosimilars/follow-on-biologics Scope and Market Size

Biosimilars/follow-on-biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/follow-on-biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Human growth hormone

- Erythropoietin

- Monoclonal antibodies

- Insulin

- Interferon

- Granulocyte-Colony Stimulating Factor

- Others

Market segment by Application, split into

- Blood disorders

- Oncology diseases

- Chronic and autoimmune diseases

- Growth hormone deficiencies

- Others

Based on regional and country-level analysis, the Biosimilars/follow-on-biologics market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Biosimilars/follow-on-biologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Novartis (Sandoz)

- Synthon Pharmaceuticals

- Teva Pharmaceutical Industries

- LG Life Sciences

- Celltrion Biocon

- Hospira

- Merck Serono (Merck)

- Biogen idec

- Genentech (Roche)

Global and United States Biosimilars/follow-on-biologics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2026
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars/follow-on-biologics Market Perspective (2015-2026)
2.2 Global Biosimilars/follow-on-biologics Growth Trends by Regions
2.2.1 Biosimilars/follow-on-biologics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biosimilars/follow-on-biologics Historic Market Share by Regions (2015-2020)
2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars/follow-on-biologics Players by Market Size
3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2015-2020)
3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2015-2020)
3.2 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue
3.4 Global Biosimilars/follow-on-biologics Market Concentration Ratio
3.4.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2019
3.5 Key Players Biosimilars/follow-on-biologics Area Served
3.6 Key Players Biosimilars/follow-on-biologics Product Solution and Service
3.7 Date of Enter into Biosimilars/follow-on-biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilars/follow-on-biologics Breakdown Data by Type (2015-2026)
4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2015-2020)
4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2021-2026)
5 Biosimilars/follow-on-biologics Breakdown Data by Application (2015-2026)
5.1 Global Biosimilars/follow-on-biologics Historic Market Size by Application (2015-2020)
5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biosimilars/follow-on-biologics Market Size (2015-2026)
6.2 North America Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
6.3 North America Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
6.4 North America Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Biosimilars/follow-on-biologics Market Size (2015-2026)
7.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
7.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
7.4 Europe Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Biosimilars/follow-on-biologics Market Size (2015-2026)
8.2 China Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
8.3 China Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
8.4 China Biosimilars/follow-on-biologics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Biosimilars/follow-on-biologics Market Size (2015-2026)
9.2 Japan Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
9.3 Japan Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
9.4 Japan Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Biosimilars/follow-on-biologics Market Size (2015-2026)
10.2 Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
10.3 Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
10.4 Southeast Asia Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Novartis (Sandoz)
11.1.1 Novartis (Sandoz) Company Details
11.1.2 Novartis (Sandoz) Business Overview
11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction
11.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2015-2020))
11.1.5 Novartis (Sandoz) Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction
11.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Details
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction
11.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.5.5 Celltrion Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Biosimilars/follow-on-biologics Introduction
11.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.6.5 Hospira Recent Development
11.7 Merck Serono (Merck)
11.7.1 Merck Serono (Merck) Company Details
11.7.2 Merck Serono (Merck) Business Overview
11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction
11.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.7.5 Merck Serono (Merck) Recent Development
11.8 Biogen idec
11.8.1 Biogen idec Company Details
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction
11.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.8.5 Biogen idec Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction
11.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.9.5 Genentech (Roche) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Human growth hormone
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Monoclonal antibodies
Table 6. Key Players of Insulin
Table 7. Key Players of Interferon
Table 8. Key Players of Granulocyte-Colony Stimulating Factor
Table 9. Key Players of Others
Table 10. Global Biosimilars/follow-on-biologics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Biosimilars/follow-on-biologics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Biosimilars/follow-on-biologics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Biosimilars/follow-on-biologics Market Share by Regions (2015-2020)
Table 14. Global Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Biosimilars/follow-on-biologics Market Share by Regions (2021-2026)
Table 16. Biosimilars/follow-on-biologics Market Market Trends
Table 17. Biosimilars/follow-on-biologics Market Drivers
Table 18. Biosimilars/follow-on-biologics Market Challenges
Table 19. Biosimilars/follow-on-biologics Market Restraints
Table 20. Global Biosimilars/follow-on-biologics Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Biosimilars/follow-on-biologics Market Share by Players (2015-2020)
Table 22. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2019)
Table 23. Global Biosimilars/follow-on-biologics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biosimilars/follow-on-biologics Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Biosimilars/follow-on-biologics Market Size Share by Type (2015-2020)
Table 29. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2021-2026)
Table 30. Global Biosimilars/follow-on-biologics Market Size Share by Application (2015-2020)
Table 31. Global Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 32. Global Biosimilars/follow-on-biologics Market Size Share by Application (2021-2026)
Table 33. North America Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 35. North America Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 37. North America Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 39. Europe Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 41. Europe Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 43. Europe Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 45. China Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 46. China Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 47. China Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 48. China Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 49. China Biosimilars/follow-on-biologics Market Size by Region (US$ Million) (2015-2020)
Table 50. China Biosimilars/follow-on-biologics Market Share by Region (2015-2020)
Table 51. Japan Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 52. Japan Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 53. Japan Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 54. Japan Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 55. Japan Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 56. Japan Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 57. Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 58. Southeast Asia Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 59. Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 60. Southeast Asia Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 61. Southeast Asia Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 62. Southeast Asia Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 63. Novartis (Sandoz) Company Details
Table 64. Novartis (Sandoz) Business Overview
Table 65. Novartis (Sandoz) Product
Table 66. Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 67. Novartis (Sandoz) Recent Development
Table 68. Synthon Pharmaceuticals Company Details
Table 69. Synthon Pharmaceuticals Business Overview
Table 70. Synthon Pharmaceuticals Product
Table 71. Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 72. Synthon Pharmaceuticals Recent Development
Table 73. Teva Pharmaceutical Industries Company Details
Table 74. Teva Pharmaceutical Industries Business Overview
Table 75. Teva Pharmaceutical Industries Product
Table 76. Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 77. Teva Pharmaceutical Industries Recent Development
Table 78. LG Life Sciences Company Details
Table 79. LG Life Sciences Business Overview
Table 80. LG Life Sciences Product
Table 81. LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 82. LG Life Sciences Recent Development
Table 83. Celltrion Biocon Company Details
Table 84. Celltrion Biocon Business Overview
Table 85. Celltrion Biocon Product
Table 86. Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 87. Celltrion Biocon Recent Development
Table 88. Hospira Company Details
Table 89. Hospira Business Overview
Table 90. Hospira Product
Table 91. Hospira Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 92. Hospira Recent Development
Table 93. Merck Serono (Merck) Company Details
Table 94. Merck Serono (Merck) Business Overview
Table 95. Merck Serono (Merck) Product
Table 96. Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 97. Merck Serono (Merck) Recent Development
Table 98. Biogen idec Business Overview
Table 99. Biogen idec Product
Table 100. Biogen idec Company Details
Table 101. Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 102. Biogen idec Recent Development
Table 103. Genentech (Roche) Company Details
Table 104. Genentech (Roche) Business Overview
Table 105. Genentech (Roche) Product
Table 106. Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 107. Genentech (Roche) Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilars/follow-on-biologics Market Share by Type: 2020 VS 2026
Figure 2. Human growth hormone Features
Figure 3. Erythropoietin Features
Figure 4. Monoclonal antibodies Features
Figure 5. Insulin Features
Figure 6. Interferon Features
Figure 7. Granulocyte-Colony Stimulating Factor Features
Figure 8. Others Features
Figure 9. Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2026
Figure 10. Blood disorders Case Studies
Figure 11. Oncology diseases Case Studies
Figure 12. Chronic and autoimmune diseases Case Studies
Figure 13. Growth hormone deficiencies Case Studies
Figure 14. Others Case Studies
Figure 15. Biosimilars/follow-on-biologics Report Years Considered
Figure 16. Global Biosimilars/follow-on-biologics Market Size (US$ Million), YoY Growth 2015-2026
Figure 17. Global Biosimilars/follow-on-biologics Market Share by Regions: 2020 VS 2026
Figure 18. Global Biosimilars/follow-on-biologics Market Share by Regions (2021-2026)
Figure 19. Global Biosimilars/follow-on-biologics Market Share by Players in 2019
Figure 20. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2019
Figure 22. North America Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. United States Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Canada Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Europe Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Germany Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. France Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. U.K. Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Italy Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Russia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Nordic Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Europe Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Asia-Pacific Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. China Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Japan Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. South Korea Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Southeast Asia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. India Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Australia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Asia-Pacific Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Latin America Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Mexico Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Brazil Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Middle East & Africa Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Turkey Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Saudi Arabia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. UAE Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Rest of Middle East & Africa Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Novartis (Sandoz) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 50. Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 52. LG Life Sciences Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 53. Celltrion Biocon Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 54. Hospira Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 55. Merck Serono (Merck) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 56. Biogen idec Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 57. Genentech (Roche) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs